Trauma and Extremities partnership aligns disciplined approach to portfolio optimization and focuses on delivering long-term ...
Spartan Medical and SI-Bone are partnering to expand spine care access to veterans. Under the partnership Spartan, a Service-Disabled Veteran-Owned Small Business distributor will offer SI-Bone’s ...
Q4 2025 Management View Laura Francis, CEO & Director, stated that "our strong fourth quarter and full year 2025 results validate that our innovation-led growth strategy is delivering meaningful ...
12d
SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance
Achieves 20% worldwide revenue growth and positive adjusted EBITDA for Fiscal Year 2025Generates free cash flow in the Fourth Quarter 2025SANTA ...
Spartan Medical® and SI-BONE® announce new partnership to expand access to advanced ultra–minimally invasive treatment ...
SANTA CLARA, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (SIBN), a Silicon Valley-based medical device company dedicated to providing surgical solutions for sacropelvic disorders, today ...
SI-BONE reports strong revenue growth and improved financial metrics for Q4 2024 and FY 2024, achieving positive adjusted EBITDA. SI-BONE, Inc. reported strong financial results for the fourth quarter ...
According to ADVFN, SI-BONE agreed to lease approximately 50,485 square feet at 88 West Plumeria Drive in North San Jose. The ...
SI-BONE, Inc., a company focused on medical technologies for sacropelvic disorders, announced it will release its financial results for the fourth quarter and full year of 2024 on February 24, 2025, ...
Si-Bone (SIBN) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- ...
SANTA CLARA, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for ...
Smith+Nephew (NYSE: SNN) today announced a distribution agreement with Si-Bone focused on the iFuse TORQ portfolio.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results